论文部分内容阅读
目的从药物经济学角度分析评价输血通注射液和长春西汀注射液治疗脑梗塞的特点。方法运用成本-效果分析法,计算2种治疗方案的治疗费用和临床疗效,并计算成本-效果比(C/E)。结果输血通组治疗费用为3 739.84元,有效率96.4%;长春西汀组治疗费用为4 587.42元,有效率97.7%,2组的C/E分别为38.78和46.95。结论输血通注射液是治疗脑梗塞的较好选择之一。
Objective To analyze and evaluate the characteristics of transfusion injection and Vinpocetine injection in the treatment of cerebral infarction from the perspective of pharmacoeconomics. Methods The cost-effectiveness analysis was used to calculate the treatment costs and clinical efficacy of the two treatment regimens, and the cost-effectiveness ratio (C / E) was calculated. Results The cost of transfusion group was 3 739.84 yuan, the effective rate was 96.4%. The cost of vinpocetine group was 4 587.42 yuan, the effective rate was 97.7%. The C / E of the two groups were 38.78 and 46.95 respectively. Conclusion Transfusion injection is one of the better options for the treatment of cerebral infarction.